메뉴 건너뛰기




Volumn 64, Issue 1, 2005, Pages 167-168

[123I]FP-CIT SPECT findings in two patients with Hallervorden-Spatz disease with homozygous mutation in PANK2 gene

Author keywords

[No Author keywords available]

Indexed keywords

PANTOTHENATE KINASE; QUETIAPINE; DIAGNOSTIC AGENT; PHOSPHOTRANSFERASE; RADIOACTIVE IODINE;

EID: 11444268286     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000148577.62644.77     Document Type: Article
Times cited : (14)

References (7)
  • 1
    • 0026738649 scopus 로고
    • Hallervorden-Spatz disease: Clinical and MRI study of 11 cases diagnosed in life
    • Angelini L, Nardocci N, Rumi V, et al. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol 1992;239:417-425.
    • (1992) J Neurol , vol.239 , pp. 417-425
    • Angelini, L.1    Nardocci, N.2    Rumi, V.3
  • 2
    • 0034935036 scopus 로고    scopus 로고
    • A novel pantothenate kinase gene is defective in Hallervorden-Spatz syndrome
    • Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene is defective in Hallervorden-Spatz syndrome. Nat Gen 2001;28:345-349.
    • (2001) Nat Gen , vol.28 , pp. 345-349
    • Zhou, B.1    Westaway, S.K.2    Levinson, B.3
  • 3
    • 0036459930 scopus 로고    scopus 로고
    • Hallervorden-Spatz syndrome (pantothenate kinase associate neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene
    • Cossu G, Melis M, Floris GL, et al. Hallervorden-Spatz syndrome (pantothenate kinase associate neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene. J Neurol 2002;249:1599-1600.
    • (2002) J Neurol , vol.249 , pp. 1599-1600
    • Cossu, G.1    Melis, M.2    Floris, G.L.3
  • 5
    • 0142248498 scopus 로고    scopus 로고
    • 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
    • 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 2003;24:149-50.
    • (2003) Neurol Sci , vol.24 , pp. 149-150
    • Antonini, A.1    Benti, R.2    De Notaris, R.3
  • 7
    • 2342435003 scopus 로고    scopus 로고
    • Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration
    • Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 2004;19:36-42.
    • (2004) Mov Disord , vol.19 , pp. 36-42
    • Thomas, M.1    Hayflick, S.J.2    Jankovic, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.